Home
VERU
VERU News

Latest Veru Inc. (VERU) News on February 23, 2025

3 US Penny Stocks With Market Caps Under $300M To Consider

Simply Wall St.

2 days ago

3 US Penny Stocks With Market Caps Under $300M To Consider

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...

GuruFocus.com

9 days ago

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

GlobeNewswire

10 days ago

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

Veru Inc (VERU) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

11 days ago

Veru Inc (VERU) Q1 2025 Earnings Report Preview: What To Expect

Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025

GlobeNewswire

17 days ago

Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025

Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

19 days ago

Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Muscle-building drug improves body composition in obesity trial, Veru says

BioPharma Dive

a month ago

Muscle-building drug improves body composition in obesity trial, Veru says

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

GlobeNewswire

a month ago

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?

Zacks

a month ago

What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?

3 US Penny Stocks With Market Caps Under $200M To Consider

Simply Wall St.

a month ago

3 US Penny Stocks With Market Caps Under $200M To Consider

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

Benzinga

2 months ago

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

MT Newswires

2 months ago

Veru Sells Female Condom Business to Riva Ridge Capital for $18 Million

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

GlobeNewswire

2 months ago

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 months ago

Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates

US Penny Stocks To Consider In December 2024

Simply Wall St.

2 months ago

US Penny Stocks To Consider In December 2024

The past three years for Veru (NASDAQ:VERU) investors has not been profitable

Simply Wall St.

2 months ago

The past three years for Veru (NASDAQ:VERU) investors has not been profitable

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

GlobeNewswire

3 months ago

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

GlobeNewswire

4 months ago

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

GlobeNewswire

4 months ago

Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

GlobeNewswire

4 months ago

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...

GuruFocus.com

4 months ago

Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...

Veru to Present at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

5 months ago

Veru to Present at the 2024 Cantor Global Healthcare Conference

Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

6 months ago

Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates

Zacks

6 months ago

Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

GlobeNewswire

6 months ago

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

GlobeNewswire

7 months ago

Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

Veru to Participate in the BTIG Virtual Biotechnology Conference

GlobeNewswire

7 months ago

Veru to Participate in the BTIG Virtual Biotechnology Conference

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

GlobeNewswire

8 months ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago

Simply Wall St.

8 months ago

Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago

Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire

8 months ago

Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

GlobeNewswire

8 months ago

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders

GlobeNewswire

8 months ago

Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire

8 months ago

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%

Simply Wall St.

9 months ago

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%

Veru to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

9 months ago

Veru to Present at the Jefferies Global Healthcare Conference

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

GlobeNewswire

9 months ago

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

GlobeNewswire

9 months ago

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

GuruFocus.com

9 months ago

Veru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial Recovery

GuruFocus.com

9 months ago

Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program

GlobeNewswire

9 months ago

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program

Veru to Present at the GLP-1 Based Therapeutics Summit

GlobeNewswire

10 months ago

Veru to Present at the GLP-1 Based Therapeutics Summit

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

GlobeNewswire

10 months ago

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

10 months ago

Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

GlobeNewswire

10 months ago

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

GlobeNewswire

10 months ago

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

What Makes Veru (VERU) a New Buy Stock

Zacks

10 months ago

What Makes Veru (VERU) a New Buy Stock

Veru Announces Date of 2024 Annual Meeting of Shareholders

GlobeNewswire

a year ago

Veru Announces Date of 2024 Annual Meeting of Shareholders

Veru Reschedules Annual Meeting of Shareholders

GlobeNewswire

a year ago

Veru Reschedules Annual Meeting of Shareholders

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

GlobeNewswire

a year ago

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

GlobeNewswire

a year ago

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

GlobeNewswire

a year ago

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

After Plunging -15.61% in 4 Weeks, Here's Why the Trend Might Reverse for Veru Inc. (VERU)

Zacks

a year ago

After Plunging -15.61% in 4 Weeks, Here's Why the Trend Might Reverse for Veru Inc. (VERU)

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q1 2024 Veru Inc Earnings Call

Veru Reports Fiscal 2024 First Quarter Financial Highlights

GlobeNewswire

a year ago

Veru Reports Fiscal 2024 First Quarter Financial Highlights

Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs

GlobeNewswire

a year ago

Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs

Charles River (CRL) to Report Q4 Earnings: What's in Store?

Zacks

a year ago

Charles River (CRL) to Report Q4 Earnings: What's in Store?

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

a year ago

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

a year ago

Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GuruFocus.com

a year ago

Provident Financial Holdings Inc Reports Mixed Fiscal Q2 Results Amid Economic Uncertainty

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

Zacks

a year ago

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

a year ago

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

BK Technologies Receives Purchase Order for BKR 9000 Radios from the Arkansas Department of Agriculture Forestry Division

ACCESSWIRE

a year ago

BK Technologies Receives Purchase Order for BKR 9000 Radios from the Arkansas Department of Agriculture Forestry Division

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

GlobeNewswire

a year ago

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

SurgePays Announces Closing of $15 Million Public Offering

GlobeNewswire

a year ago

SurgePays Announces Closing of $15 Million Public Offering

Vaxxinity & UCF to Collaborate on Space Medicine Research

Exec Edge

a year ago

Vaxxinity & UCF to Collaborate on Space Medicine Research

Nine Energy Service Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Business Wire

a year ago

Nine Energy Service Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Chijet Motor Company, Inc. Signs Strategic Agreement to Improve Automotive Cybersecurity

GlobeNewswire

a year ago

Chijet Motor Company, Inc. Signs Strategic Agreement to Improve Automotive Cybersecurity

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

GlobeNewswire

a year ago

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript

Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)

GuruFocus.com

a year ago

Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)

Asure Software (ASUR) Enhances Payroll With SAP Integration

Zacks

a year ago

Asure Software (ASUR) Enhances Payroll With SAP Integration

The ONE Group Hospitality, Inc. Opens STK Boston

Business Wire

a year ago

The ONE Group Hospitality, Inc. Opens STK Boston

Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

GlobeNewswire

a year ago

Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%

Simply Wall St.

a year ago

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%

Further Upside For Maiden Holdings, Ltd. (NASDAQ:MHLD) Shares Could Introduce Price Risks After 38% Bounce

Simply Wall St.

a year ago

Further Upside For Maiden Holdings, Ltd. (NASDAQ:MHLD) Shares Could Introduce Price Risks After 38% Bounce

Veru Announces Pricing of Public Offering of Common Stock

GlobeNewswire

a year ago

Veru Announces Pricing of Public Offering of Common Stock

FS Bancorp, Inc. (NASDAQ:FSBW) is a favorite amongst institutional investors who own 67%

Simply Wall St.

a year ago

FS Bancorp, Inc. (NASDAQ:FSBW) is a favorite amongst institutional investors who own 67%

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

Zacks

a year ago

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

CPI Card Group Announces Share Purchase Agreement with Majority Shareholder Parallel49 Equity ULC

Business Wire

a year ago

CPI Card Group Announces Share Purchase Agreement with Majority Shareholder Parallel49 Equity ULC

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vertical Receives Continued Listing Standard Notice from NYSE

Business Wire

a year ago

Vertical Receives Continued Listing Standard Notice from NYSE

Old Point Financial Corporation (NASDAQ:OPOF) Passed Our Checks, And It's About To Pay A US$0.14 Dividend

Simply Wall St.

a year ago

Old Point Financial Corporation (NASDAQ:OPOF) Passed Our Checks, And It's About To Pay A US$0.14 Dividend

Citi Trends Inc (CTRN) Reports Decline in Q3 Sales and Earnings

GuruFocus.com

a year ago

Citi Trends Inc (CTRN) Reports Decline in Q3 Sales and Earnings

Middlefield Banc Corp. Announces 2023 Fourth Quarter Cash Dividend Payment and Declares a $0.05 Special Cash Dividend Payment

GlobeNewswire

a year ago

Middlefield Banc Corp. Announces 2023 Fourth Quarter Cash Dividend Payment and Declares a $0.05 Special Cash Dividend Payment

Valens Semiconductor Reports Third Quarter 2023 Results

PR Newswire

a year ago

Valens Semiconductor Reports Third Quarter 2023 Results

Voya Investment Management, to host a webcast for the Voya Asia Pacific High Dividend Equity Income Fund and Voya Emerging Markets High Dividend Equity Fund

Business Wire

a year ago

Voya Investment Management, to host a webcast for the Voya Asia Pacific High Dividend Equity Income Fund and Voya Emerging Markets High Dividend Equity Fund

Share on Social Networks: